Literature DB >> 17462627

Distinct functional domains in nesprin-1alpha and nesprin-2beta bind directly to emerin and both interactions are disrupted in X-linked Emery-Dreifuss muscular dystrophy.

Matthew A Wheeler1, John D Davies, Qiuping Zhang, Lindsay J Emerson, James Hunt, Catherine M Shanahan, Juliet A Ellis.   

Abstract

Emerin and specific isoforms of nesprin-1 and -2 are nuclear membrane proteins which are binding partners in multi-protein complexes spanning the nuclear envelope. We report here the characterisation of the residues both in emerin and in nesprin-1alpha and -2beta which are involved in their interaction and show that emerin requires nesprin-1 or -2 to retain it at the nuclear membrane. Using several protein-protein interaction methods, we show that residues 368 to 627 of nesprin-1alpha and residues 126 to 219 of nesprin-2beta, which show high homology to one another, both mediate binding to emerin residues 140-176. This region has previously been implicated in binding to F-actin, beta-catenin and lamin A/C suggesting that it is critical for emerin function. Confirmation that these protein domains interact in vivo was shown using GFP-dominant negative assays. Exogenous expression of either of these nesprin fragments in mouse myoblast C2C12 cells displaced endogenous emerin from the nuclear envelope and reduced the targeting of newly synthesised emerin. Furthermore, we are the first to report that emerin mutations which give rise to X-linked Emery-Dreifuss muscular dystrophy, disrupt binding to both nesprin-1alpha and -2beta isoforms, further indicating a role of nesprins in the pathology of Emery-Dreifuss muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462627     DOI: 10.1016/j.yexcr.2007.03.025

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  49 in total

Review 1.  The nucleoskeleton as a genome-associated dynamic 'network of networks'.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Nat Rev Mol Cell Biol       Date:  2011-10-05       Impact factor: 94.444

Review 2.  Nuclear lamins.

Authors:  Thomas Dechat; Stephen A Adam; Pekka Taimen; Takeshi Shimi; Robert D Goldman
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-08       Impact factor: 10.005

Review 3.  Lamin-binding Proteins.

Authors:  Katherine L Wilson; Roland Foisner
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02-17       Impact factor: 10.005

Review 4.  Interactions between nuclei and the cytoskeleton are mediated by SUN-KASH nuclear-envelope bridges.

Authors:  Daniel A Starr; Heidi N Fridolfsson
Journal:  Annu Rev Cell Dev Biol       Date:  2010       Impact factor: 13.827

Review 5.  Moving and positioning the nucleus in skeletal muscle - one step at a time.

Authors:  Bruno Cadot; Vincent Gache; Edgar R Gomes
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

Review 6.  Nuclear Mechanics and Stem Cell Differentiation.

Authors:  Xinjian Mao; Nuria Gavara; Guanbin Song
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

Review 7.  Making the LINC: SUN and KASH protein interactions.

Authors:  Dae In Kim; K C Birendra; Kyle J Roux
Journal:  Biol Chem       Date:  2015-04       Impact factor: 3.915

8.  An emerin "proteome": purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture.

Authors:  James M Holaska; Katherine L Wilson
Journal:  Biochemistry       Date:  2007-07-10       Impact factor: 3.162

Review 9.  Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus.

Authors:  Ning Wang; Jessica D Tytell; Donald E Ingber
Journal:  Nat Rev Mol Cell Biol       Date:  2009-01       Impact factor: 94.444

Review 10.  Experimental techniques for study of chromatin mechanics in intact nuclei and living cells.

Authors:  Valerie L R M Verstraeten; Jan Lammerding
Journal:  Chromosome Res       Date:  2008       Impact factor: 5.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.